| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/19/1996 | CA2451970A1 Method to aid refolding of tissue factor pathway inhibitor |
| 12/19/1996 | CA2451969A1 Method of purifying tissue factor pathway inhibitor |
| 12/19/1996 | CA2450953A1 Method of solubilizing, purifying, and refolding protein |
| 12/19/1996 | CA2450804A1 Method of solubilizing, purifying, and refolding protein |
| 12/19/1996 | CA2450800A1 Method of solubilizing, purifying, and refolding protein |
| 12/19/1996 | CA2450797A1 Method of solubilizing proteins containing two oppositely-charged domains |
| 12/19/1996 | CA2450795A1 Method of refolding tissue factor pathway inhibitor |
| 12/19/1996 | CA2288401A1 Icam-4 materials and methods |
| 12/19/1996 | CA2228998A1 Prevention and treatment of sepsis |
| 12/19/1996 | CA2228277A1 Agonist peptide dimers |
| 12/19/1996 | CA2226546A1 Promotion of homologous dna pairing by reca-derived peptides |
| 12/19/1996 | CA2224232A1 Methods, kits, and compositions for diagnosing papillomavirus infection |
| 12/19/1996 | CA2224205A1 Fused soluble mhc heterodimer-peptide complexes and their uses |
| 12/19/1996 | CA2224184A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof |
| 12/19/1996 | CA2224174A1 Method for obtaining receptor agonist antibodies |
| 12/19/1996 | CA2224172A1 Use of gram-positive bacteria to express recombinant proteins |
| 12/19/1996 | CA2224099A1 Monocyte chemotactic protein-4 |
| 12/19/1996 | CA2224097A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 12/19/1996 | CA2224015A1 Streptococcal heat shock proteins members of the hsp70 family |
| 12/19/1996 | CA2224014A1 3' utr of the human prohibitin gene |
| 12/19/1996 | CA2224012A1 Developmentally-regulated endothelial cell locus-1 |
| 12/19/1996 | CA2223969A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 12/19/1996 | CA2223940A1 Macrophage activating factors derived from cloned vitamin d binding protein |
| 12/19/1996 | CA2223934A1 Separation of active complexes |
| 12/19/1996 | CA2223924A1 Iodine-containing peptides |
| 12/19/1996 | CA2223891A1 Treatment of insulin resistance |
| 12/19/1996 | CA2223878A1 Inhibitors of phospholipase a2 |
| 12/19/1996 | CA2223832A1 Method for the treatment of corticosteroid induced osteopenia |
| 12/19/1996 | CA2223737A1 Use of conotoxin peptides u002 and mii for treating or detecting small-cell lung carcinoma |
| 12/19/1996 | CA2223717A1 Modified steroid hormones for gene therapy and methods for their use |
| 12/19/1996 | CA2223714A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease |
| 12/19/1996 | CA2223687A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies |
| 12/19/1996 | CA2223611A1 Appetite regulating compositions |
| 12/19/1996 | CA2223610A1 Nucleic acid respiratory syncytial virus vaccines |
| 12/19/1996 | CA2223608A1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 12/19/1996 | CA2223605A1 Stable formulations of mhc-peptide complexes |
| 12/19/1996 | CA2223599A1 Hiv-1 prophylactic composition and method |
| 12/19/1996 | CA2223577A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
| 12/19/1996 | CA2223531A1 Reducing gelation of a fatty acid-acylated protein |
| 12/19/1996 | CA2223519A1 Methods for evaluation of antimicrobial targets |
| 12/19/1996 | CA2223512A1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 12/19/1996 | CA2223495A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
| 12/19/1996 | CA2223494A1 Chromosomal expression of heterologous genes in bacterial cells |
| 12/19/1996 | CA2223493A1 Recombinant viral nucleic acids |
| 12/19/1996 | CA2223459A1 Regulatory elements conferring tapetum specificity |
| 12/19/1996 | CA2223446A1 Thrombopoietin compositions |
| 12/19/1996 | CA2223440A1 Fucosyltransferase genes and uses thereof |
| 12/19/1996 | CA2223428A1 Novel mu opioid receptor ligands: agonists and antagonists |
| 12/19/1996 | CA2223416A1 Recombinant poxvirus-rabies compositions and combination compositions and uses |
| 12/19/1996 | CA2223395A1 Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics |
| 12/19/1996 | CA2223389A1 Preparation of an acylated protein powder |
| 12/19/1996 | CA2223381A1 Monoclonal antibody detection of proteins on sperm related to fertility |
| 12/19/1996 | CA2223292A1 Single chain analogs of the tgf-.beta. superfamily (morphons) |
| 12/19/1996 | CA2223278A1 Method for the isolation of lipoprotein (a) allowing for the subsequent quantification of its mass and cholesterol content |
| 12/19/1996 | CA2223277A1 Method for detection of antibody to hepatitis c virus second envelope glycoprotein |
| 12/19/1996 | CA2223268A1 .alpha.-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 12/19/1996 | CA2223262A1 Lymphocyte chemoattractant factor and uses thereof |
| 12/19/1996 | CA2223246A1 Cell line producing analgesic compounds for treating pain |
| 12/19/1996 | CA2223182A1 Expression system for non-secretor genes |
| 12/19/1996 | CA2223143A1 Peptide fragments of tissue factor and their use for treatment and prevention of clotting disorders |
| 12/19/1996 | CA2223104A1 Pcr-based cdna subtractive cloning method |
| 12/19/1996 | CA2223086A1 Novel serpin derived from human hypothalamus |
| 12/19/1996 | CA2223077A1 Thrombin receptor homolog |
| 12/19/1996 | CA2223041A1 Immunological combination compositions and methods |
| 12/19/1996 | CA2223003A1 High-affinity nucleic acid ligands of cytokines |
| 12/19/1996 | CA2222999A1 Novel ctla4/cd28 ligands and uses therefor |
| 12/19/1996 | CA2222994A1 Peptides for hiv-1 detection |
| 12/19/1996 | CA2222947A1 Inhibin compositions and methods of enhancing production performance |
| 12/19/1996 | CA2222789A1 Bone stimulating factor |
| 12/19/1996 | CA2222690A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits |
| 12/19/1996 | CA2222562A1 Method for screening for receptor agonists and antagonists |
| 12/19/1996 | CA2222551A1 Tumor associated epitopes |
| 12/19/1996 | CA2222550A1 Nucleic acid transporters for delivery of nucleic acids into a cell |
| 12/19/1996 | CA2222520A1 Oligonucleotides specific for cytokine signal transducer gp130 mrna |
| 12/19/1996 | CA2222239A1 A method of crosslinking amino acid-containing polymers using photoactivatable chemical cross-linkers |
| 12/19/1996 | CA2222183A1 Stable reagents for the preparation of radiopharmaceuticals |
| 12/19/1996 | CA2222174A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models |
| 12/19/1996 | CA2222162A1 Pericardial therapeutic and diagnostic agent delivery |
| 12/19/1996 | CA2221986A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models |
| 12/19/1996 | CA2221821A1 Endothelial-monocyte activating polypeptide iii |
| 12/19/1996 | CA2221780A1 Anti-fungal d-amino acid histatin-based peptides |
| 12/19/1996 | CA2221747A1 Cotton fiber transcriptional factors |
| 12/19/1996 | CA2221726A1 Use of ovary-tissue transcriptional factors |
| 12/19/1996 | CA2221646A1 Synthetic peptides and pharmaceutical compositions comprising them |
| 12/19/1996 | CA2221570A1 Neutralizing conformation epitopes of chicken anemia virus |
| 12/19/1996 | CA2221480A1 Mutants of streptococcal toxin a and methods of use |
| 12/19/1996 | CA2221313A1 Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus |
| 12/19/1996 | CA2221240A1 Controlling hemipteran insect pests with bacillus thuringiensis |
| 12/19/1996 | CA2220952A1 Anti-allergy bispecific molecules |
| 12/19/1996 | CA2220459A1 Expression of functional vertebrate phospholipases in yeast |
| 12/19/1996 | CA2219242A1 Modified hemoglobin-like compounds and methods of purifying same |
| 12/19/1996 | CA2197244A1 Wound healing formulations containing human plasma fibronectin |
| 12/19/1996 | CA2196691A1 Macrophage derived chemokine and chemokine analogs |
| 12/18/1996 | EP0748871A1 Phage-resistant streptococcus |
| 12/18/1996 | EP0748870A2 Oncostatin M induced hematopoiesis |
| 12/18/1996 | EP0748869A1 Ectoine synthetase gene |
| 12/18/1996 | EP0748868A2 Ceramide glucosyltransferase |
| 12/18/1996 | EP0748817A2 Parathyroid hormone derivatives and their use |
| 12/18/1996 | EP0748816A1 Toxoplasma gondii antigen, its production and use |
| 12/18/1996 | EP0748815A1 Toxoplasma gondii antigen, its production and use |